Senate panel to hear from pharmacy middlemen on drug prices

21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major ...

Read more →

Institute for Clinical and Economic Review appoints new members to each of its three independent evidence appraisal councils

18 March 2019 - New members bring expertise in broad range of perspectives, including patient advocacy, health policy, economics, and clinical ...

Read more →

Cancer Institute's Sharpless tapped as acting chief of FDA

12 March 2019 - Ned Sharpless, the director of the National Cancer Institute, will be named temporary chief of the ...

Read more →

Donald Trump just lost his most popular bureaucrat

6 March 2019 - U.S. FDA Commissioner Scott Gottlieb is resigning and will leave the agency in a month, according to ...

Read more →

FDA chief tough on e-cigs steps down in surprise resignation

5 March 2019 - U.S. FDA Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a ...

Read more →

CEOs hide as pressure on drug prices grows

30 January 2019 - This week, key committees in the House and Senate each held hearings on the rising cost ...

Read more →

The FDA has five weeks till money runs out for approving new drugs

16 January 2019 - The US FDA has roughly five weeks of funding left to review new drug applications during ...

Read more →

EMA to lose 25% of staff as hard Brexit approaches

14 January 2019 - As UK Prime Minister Theresa May’s Brexit deal is expected to be rejected Tuesday in a ...

Read more →

If the shutdown drags on at FDA, it will put anticipated new treatments in jeopardy

14 January 2019 - The government shutdown could soon jeopardise highly anticipated new drugs from Janssen, Sanofi, and Novartis for ...

Read more →

Cost recovery and Pharmaceutical Benefits Scheme process improvements information forums

14 January 2019 - The Department of Health will be hosting information forums in both Sydney and Melbourne regarding amendments ...

Read more →

Partial government shutdown's impact on FDA drug approvals

10 January 2019 - As the partial federal government shutdown drags on into its third week, its impact is being felt ...

Read more →

All seven of the FDA’s recent commissioners agree it should be independent — but not on how to accomplish it

7 January 2019 - Nearly every person who’s run the FDA in recent history agrees the agency should break free ...

Read more →

FDA plans to create a new office to leverage cutting-edge science

7 January 2019 - The FDA plans to create a new office to improve the review of new medicines — ...

Read more →

Department update: implementation of the improved payment administration arrangements

2 January 2019 - A communique describing key achievements for 2018, and important next steps for 2019 is now available on ...

Read more →

ICER opens nominations for new members of its voting panels

5 December 2018 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other health ...

Read more →